John A. McLane

1.1k total citations
21 papers, 775 citations indexed

About

John A. McLane is a scholar working on Molecular Biology, Dermatology and Cell Biology. According to data from OpenAlex, John A. McLane has authored 21 papers receiving a total of 775 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Dermatology and 6 papers in Cell Biology. Recurrent topics in John A. McLane's work include Hormonal and reproductive studies (5 papers), Vitamin D Research Studies (4 papers) and melanin and skin pigmentation (4 papers). John A. McLane is often cited by papers focused on Hormonal and reproductive studies (5 papers), Vitamin D Research Studies (4 papers) and melanin and skin pigmentation (4 papers). John A. McLane collaborates with scholars based in United States, Switzerland and Canada. John A. McLane's co-authors include Milan R. Uskoković, George P. Studzinski, John M. Pawelek, G. Satyanarayana Reddy, Kou‐Yi Tserng, Jonathan Larkin, Christopher D. Stubbs, Cojen Ho, Simon J. Slater and Mark D. Yeager and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Biochemistry.

In The Last Decade

John A. McLane

21 papers receiving 747 citations

Peers

John A. McLane
Allen S. W. Oak United States
David Hsieh United States
Thomas R. Berton United States
Xin Guo Japan
Gerhard Lutz Germany
John A. McLane
Citations per year, relative to John A. McLane John A. McLane (= 1×) peers Jiro Hosomi

Countries citing papers authored by John A. McLane

Since Specialization
Citations

This map shows the geographic impact of John A. McLane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. McLane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. McLane more than expected).

Fields of papers citing papers by John A. McLane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. McLane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. McLane. The network helps show where John A. McLane may publish in the future.

Co-authorship network of co-authors of John A. McLane

This figure shows the co-authorship network connecting the top 25 collaborators of John A. McLane. A scholar is included among the top collaborators of John A. McLane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. McLane. John A. McLane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Twardowski, Przemyslaw, et al.. (2018). Nadir testosterone (T) following in-situ polymer delivered, subcutaneously administered leuprolide acetate in men with prostate cancer (PCa).. Journal of Clinical Oncology. 36(6_suppl). 204–204. 1 indexed citations
2.
Saltzstein, Daniel R., Neal D. Shore, Judd W. Moul, et al.. (2017). Pharmacokinetic and pharmacodynamic comparison of subcutaneous versus intramuscular leuprolide acetate formulations in male subjects. Therapeutic Advances in Urology. 10(2). 43–50. 19 indexed citations
3.
Atkinson, Stuart, et al.. (2017). Polymer-delivered, subcutaneously administered leuprolide acetate provides consistent and prolonged drug delivery in castrate men with advanced prostate cancer.. Journal of Clinical Oncology. 35(6_suppl). e586–e586. 1 indexed citations
4.
5.
Pither, Richard, et al.. (2009). P-48: The use of Cytostar-T™ scintillating microplates to monitor insulin-dependent glucose uptake by 3T3-L1 adipocytes. Experimental and Clinical Endocrinology & Diabetes. 104(S 02). 115–116. 1 indexed citations
6.
McLane, John A.. (2001). Analysis of common side effects of isotretinoin. Journal of the American Academy of Dermatology. 45(5). S188–S194. 108 indexed citations
7.
Reddy, G. Satyanarayana, Krishnamurthi Muralidharan, William H. Okamura, Kou‐Yi Tserng, & John A. McLane. (2001). Metabolism of 1α,25-dihydroxyvitamin D3 and its C-3 epimer 1α,25-dihydroxy-3-epi-vitamin D3 in neonatal human keratinocytes. Steroids. 66(3-5). 441–450. 55 indexed citations
8.
Strauss, John S., Alice B. Gottlieb, Terry M. Jones, et al.. (2000). Concomitant administration of vitamin E does not change the side effects of isotretinoin as used in acne vulgaris: A randomized trial. Journal of the American Academy of Dermatology. 43(5). 777–784. 27 indexed citations
9.
McLane, John A., et al.. (1996). Modulation of epidermal differentiation, tissue inflammation, and T‐lymphocyte infiltration in psoriatic plaques by topical calcitriol. Journal of Cutaneous Pathology. 23(5). 419–430. 15 indexed citations
10.
Slater, Simon J., Mary Beth Kelly, Frank J. Taddeo, et al.. (1995). Direct Activation of Protein Kinase C by 1α,25-Dihydroxyvitamin D3. Journal of Biological Chemistry. 270(12). 6639–6643. 109 indexed citations
11.
Reddy, G. Satyanarayana, Jeffrey W. Clark, Kou‐Yi Tserng, Milan R. Uskoković, & John A. McLane. (1993). Metabolism of 1,25(OH)216-ene D3 in kidney: influence of structural modification of d-ring on side chain metabolism. Bioorganic & Medicinal Chemistry Letters. 3(9). 1879–1884. 19 indexed citations
12.
Studzinski, George P., John A. McLane, & Milan R. Uskoković. (1993). Signaling pathways for vitamin D-induced differentiation: implications for therapy of proliferative and neoplastic diseases.. PubMed. 3(4). 279–312. 90 indexed citations
13.
Longley, Ross E., Sarath P. Gunasekera, D A Faherty, John A. McLane, & Francis J. Dumont. (1993). Immunosuppression by Discodermolide. Annals of the New York Academy of Sciences. 696(1). 94–107. 42 indexed citations
14.
McLane, John A., et al.. (1992). 1,25‐dihydroxy‐vitamin‐D3 enhances antiproliferative effect and transcription of TGF‐β1 on human keratinocytes in culture. Journal of Cellular Physiology. 151(3). 579–587. 48 indexed citations
15.
McLane, John A., et al.. (1990). Effect of 1,25-dihydroxyvitamin D3 on human keratinocytes grown under different culture conditions. In Vitro Cellular & Developmental Biology - Plant. 26(4). 379–387. 54 indexed citations
16.
Sauder, Daniel N., P L Kilian, John A. McLane, et al.. (1990). Interleukin-1 enhances epidermal wound healing.. PubMed. 9(4). 465–73. 86 indexed citations
17.
McLane, John A. & John M. Pawelek. (1988). Receptors for .beta.-melanocyte-stimulating hormone exhibit positive cooperativity in synchronized melanoma cells. Biochemistry. 27(10). 3743–3747. 33 indexed citations
18.
Pawelek, John M., et al.. (1988). A possible role for melanin precursors in regulating both pigmentation and proliferation of melanocytes.. PubMed. 256. 143–54. 12 indexed citations
19.
McLane, John A., et al.. (1988). Differential Effects of 1,25‐Dihydroxy‐vitamin D3 on Proliferation and Biochemical Differentiation of Cultured Human Epidermal Keratinocytes Grown in Different Media. Annals of the New York Academy of Sciences. 548(1). 341–343. 6 indexed citations
20.
McLane, John A., et al.. (1987). Phosphorylated isomers of L-dopa stimulate MSH binding capacity and responsiveness to MSH in cultured melanoma cells. Biochemical and Biophysical Research Communications. 145(2). 719–725. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026